• Employees
  • Careers
  • Investors
  • News
  • Partners
  • Contact Us
Find
  • Our Company
  • Our Caring
  • Our Products
  • Home
  • Investor Relations
    • Annual Reports & Proxy
    • Awards & Recognition
    • Company Information
    • Corporate Governance
    • Financial Information
    • News Releases
    • Pharmaceutical Pipeline
    • SEC Filings
    • Shareholder Services
    • Stock Information
    • Webcasts & Presentations
    • Investor Tools
    • Investor Contacts
Investor Relations  >  Corporate Governance  >  Board of Directors
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Board of Directors

Our Board of Directors is a group of people who meet a set of General Criteria for membership and are elected to the Board by our shareholders each year. We currently have 11 Board members, 10 of whom are "independent" under the rules of the New York Stock Exchange.

Our Board holds the ultimate authority of our Company, except to the extent that shareholders are granted certain powers under the Company's Certificate of Incorporation and By-Laws.

The Board:

  • Appoints senior management of the Company, who are responsible for conducting business and operations,
  • Provides oversight of management, and
  • Forms standing Board Committees to assist in fulfilling its obligations.

Our Management Team meets throughout each year with our Board members to discuss strategic direction and major developments of the Company's various businesses.

Our Directors are:

Mary Sue Coleman, Ph.D.
President, University of Michigan
James G. Cullen
Retired President and Chief Operating Officer, Bell Atlantic Corporation
Michael M.E. Johns, M.D.
Chancellor, Emory University
Arnold G. Langbo
Retired Chairman and Chief Executive Officer, Kellogg Company
Susan L. Lindquist, Ph.D.
Member and Former Director, Whitehead Institute for Biomedical Research; Professor of Biology, Massachusetts Institute of Technology
Anne M. Mulcahy
Chairman, Xerox Corporation
Leo F. Mullin
Retired Chairman and Chief Executive Officer, Delta Air Lines, Inc.
William D. Perez
Retired President and Chief Executive Officer, Wm. Wrigley Jr. Company
Charles Prince
Chairman, Sconset Group LLC; Vice Chairman and Chairman of the Board of Advisors, Stonebridge International LLC; Retired Chairman and Chief Executive Officer, Citigroup Inc.
David Satcher, M.D., Ph.D.
Director, Center of Excellence on Health Disparities, Director, Satcher Health Leadership Institute and Poussaint-Satcher-Cosby Chair in Mental Health, Morehouse School of Medicine
William C. Weldon
Chairman, Board of Directors and Chief Executive Officer, Chairman, Executive Committee

Find out more about:

Director Nomination Process
Strategic Planning Process
Communication with the Board
Board Committees
Our Management Team

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc. 1997-2009. All Rights Reserved.
  • Employees
  • Careers
  • Investors
  • News
  • Partners
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Our Management Approach

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.
All contents © Johnson & Johnson Services, Inc. 1997-2009. All Rights Reserved.